Biden Warns: China Could "Eat Our Lunch" When it Comes to Lithium
Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition.
Get the full scoop on this investment opportunity
James T. Treace, insider at Treace Medical Concepts
James T. Treace Insider Alerts

Get notified the next time James T. Treace buys or sells Treace Medical Concepts stock. Enter your email address below to get our daily insider buying and selling report.

James T. Treace Insider Information

James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.

How do I contact James T. Treace?

The corporate mailing address for Mr. Treace and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]

Has James T. Treace been buying or selling shares of Treace Medical Concepts?

During the last ninety days, James T. Treace has sold $1,623,430.00 in Treace Medical Concepts stock. Most recently, James T. Treace sold 17,000 shares of the business's stock in a transaction on Wednesday, November 24th. The shares were sold at an average price of $17.83, for a transaction totalling $303,110.00.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), and John Treace (CEO).

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, Treace Medical Concepts insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $170,000.00. During the last twelve months, insiders at the sold shares 13 times. They sold a total of 6,301,372 shares worth more than $108,121,242.02. The most recent insider tranaction occured on November, 24th when Director James T Treace sold 17,000 shares worth more than $303,110.00.

Information on this page was last updated on 11/24/2021.

James T. Treace Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/24/2021Sell17,000$17.83$303,110.00View SEC Filing Icon  
11/22/2021Sell16,000$18.52$296,320.00View SEC Filing Icon  
11/17/2021Sell25,000$20.33$508,250.00View SEC Filing Icon  
11/15/2021Sell25,000$20.63$515,750.00View SEC Filing Icon  
See Full Table

James T. Treace Buying and Selling Activity at Treace Medical Concepts

This chart shows James T Treace's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
Read More

Today's Range

Now: $17.26
Low: $16.86
High: $18.36

50 Day Range

MA: $23.70
Low: $17.52
High: $29.35

2 Week Range

Now: $17.26
Low: $16.57
High: $37.17

Volume

6,374 shs

Average Volume

243,326 shs

Market Capitalization

$917.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Biden Warns: China Could "Eat Our Lunch" When it Comes to Lithium
Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition.
Get the full scoop on this investment opportunity